(Q63408388)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11464222%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Fas-ligand and immune privilege: the eyes have it (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11464222%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11464222%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Ferguson TA

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11464222%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 July 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11464222%20AND%20SRC:MED&resulttype=core&format=json

Cell Death & Differentiation

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11464222%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11464222%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11464222%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

771-772

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11464222%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4400891

9 November 2019

exact match

0 references

cites work

Countering the 'counterattack' hypothesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

Immune privilege or inflammation? Insights into the Fas ligand enigma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

Fas ligand (CD95 ligand) controls angiogenesis beneath the retina

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

Fas and Fas Ligand Expressed on Cells of the Immune System, not on the Target Tissue, Control Induction of Experimental Autoimmune Uveitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

A vision of cell death: insights into immune privilege

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

Regulation of the proinflammatory effects of Fas ligand (CD95L).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

Role of Fas-mediated cell death in the regulation of immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

Specificity questions concerning the clone 33 anti-fas ligand antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

Antibody mAb33 from transduction laboratories detects human CD95L in ELISA but not in immunoblots

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021

mAb 33 from Transduction Laboratories specifically binds to human CD95-L

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4400891

7 January 2021